113 related articles for article (PubMed ID: 25413595)
21. A Novel Fusion Partner, SP100, Drives Nuclear Dot Localization of ALK in Epithelioid Fibrous Histiocytoma.
Russell-Goldman E; Dong F; Laga A; Hanna J
Am J Dermatopathol; 2023 Aug; 45(8):539-543. PubMed ID: 37377191
[TBL] [Abstract][Full Text] [Related]
22. Kinase expression in angiomatoid fibrous histiocytoma: panTRK is commonly expressed in the absence of
Vargas AC; Joy C; Maclean FM; Bonar F; Wong DD; Gill AJ; Cheah AL
J Clin Pathol; 2024 Mar; 77(4):251-254. PubMed ID: 38053271
[TBL] [Abstract][Full Text] [Related]
23. A cutaneous inflammatory myofibroblastic tumour with ALK rearrangement in the upper extremity.
Cantile M; Aquino G; Franco R; Marra L; Gallo M; De Chiara A
Pathology; 2014 Oct; 46(6):575-6. PubMed ID: 25158817
[No Abstract] [Full Text] [Related]
24. Epithelioid Fibrous Histiocytoma: A Concise Review.
Felty CC; Linos K
Am J Dermatopathol; 2019 Dec; 41(12):879-883. PubMed ID: 30289773
[TBL] [Abstract][Full Text] [Related]
25. Distinct ALK-rearranged and VCL-negative papillary renal cell carcinoma variant in two adults without sickle cell trait.
Hodge JC; Pearce KE; Sukov WR
Mod Pathol; 2013 Apr; 26(4):604-5. PubMed ID: 23542520
[No Abstract] [Full Text] [Related]
26. Reply to 'Distinct ALK-rearranged and VCL-negative papillary renal cell carcinoma variants in two adults without sickle cell trait'.
Debelenko LV
Mod Pathol; 2013 Apr; 26(4):605-7. PubMed ID: 23542521
[No Abstract] [Full Text] [Related]
27. Aneurysmal fibrous histiocytomas with recurrent rearrangement of the PRKCD gene and LAMTOR1-PRKCD fusions.
Jedrych JJ; Duraisamy S; Karunamurthy A
J Cutan Pathol; 2018 Dec; 45(12):966-968. PubMed ID: 30094855
[No Abstract] [Full Text] [Related]
28. Clinical, histopathologic, and genomic features of Spitz tumors with ALK fusions.
Yeh I; de la Fouchardiere A; Pissaloux D; Mully TW; Garrido MC; Vemula SS; Busam KJ; LeBoit PE; McCalmont TH; Bastian BC
Am J Surg Pathol; 2015 May; 39(5):581-91. PubMed ID: 25602801
[TBL] [Abstract][Full Text] [Related]
29. Pulmonary inflammatory myofibroblastic tumor expressing a novel fusion, PPFIBP1-ALK: reappraisal of anti-ALK immunohistochemistry as a tool for novel ALK fusion identification.
Takeuchi K; Soda M; Togashi Y; Sugawara E; Hatano S; Asaka R; Okumura S; Nakagawa K; Mano H; Ishikawa Y
Clin Cancer Res; 2011 May; 17(10):3341-8. PubMed ID: 21430068
[TBL] [Abstract][Full Text] [Related]
30. Cutaneous VCL::ALK fusion ovoid-spindle cell neoplasm.
Helm M; Chang A; Fanburg-Smith JC; Zaenglein AL; Helm K
J Cutan Pathol; 2023 May; 50(5):405-409. PubMed ID: 36843055
[TBL] [Abstract][Full Text] [Related]
31. Detection of ALK rearrangement by immunohistochemistry in lung adenocarcinoma and the identification of a novel EML4-ALK variant.
To KF; Tong JH; Yeung KS; Lung RW; Law PP; Chau SL; Kang W; Tong CY; Chow C; Chan AW; Leung LK; Mok TS
J Thorac Oncol; 2013 Jul; 8(7):883-91. PubMed ID: 23625156
[TBL] [Abstract][Full Text] [Related]
32. Analyzing the morphological spectrum of epithelioid fibrous histiocytoma and the immunohistochemical performance of the ALK D5F3 and ALK1 clones.
Moayed-Alaei L; Vargas AC; Adybeik D; Maclean F; Moir D
Hum Pathol; 2022 Feb; 120():46-56. PubMed ID: 34929229
[TBL] [Abstract][Full Text] [Related]
33. Effective enrichment strategy for EML4-ALK fusion gene screening in patients with non-small cell lung cancer.
Kobayashi M; Sakakibara T; Inoue A; Fukuhara T; Sasano H; Ichinose M; Nukiwa T
Respir Investig; 2014 Jan; 52(1):49-56. PubMed ID: 24388371
[TBL] [Abstract][Full Text] [Related]
34. Inflammatory myofibroblastic tumour of the lung with a novel PPFIBP1-ALK fusion variant.
Yoshida A; Shibata T; Tsuta K; Watanabe S; Tsuda H
Histopathology; 2013 Dec; 63(6):881-3. PubMed ID: 23957430
[No Abstract] [Full Text] [Related]
35. Identification of EGFR mutation, KRAS mutation, and ALK gene rearrangement in cytological specimens of primary and metastatic lung adenocarcinoma.
Cai G; Wong R; Chhieng D; Levy GH; Gettinger SN; Herbst RS; Puchalski JT; Homer RJ; Hui P
Cancer Cytopathol; 2013 Sep; 121(9):500-7. PubMed ID: 23495083
[TBL] [Abstract][Full Text] [Related]
36. Detection of ALK gene rearrangement in non-small cell lung cancer: a comparison of fluorescence in situ hybridization and chromogenic in situ hybridization with correlation of ALK protein expression.
Kim H; Yoo SB; Choe JY; Paik JH; Xu X; Nitta H; Zhang W; Grogan TM; Lee CT; Jheon S; Chung JH
J Thorac Oncol; 2011 Aug; 6(8):1359-66. PubMed ID: 21587085
[TBL] [Abstract][Full Text] [Related]
37. Anaplastic lymphoma kinase rearrangement in lung cancer: its biological and clinical significance.
Toyokawa G; Seto T
Respir Investig; 2014 Nov; 52(6):330-8. PubMed ID: 25453376
[TBL] [Abstract][Full Text] [Related]
38. Detection of circulating tumor cells harboring a unique ALK rearrangement in ALK-positive non-small-cell lung cancer.
Pailler E; Adam J; Barthélémy A; Oulhen M; Auger N; Valent A; Borget I; Planchard D; Taylor M; André F; Soria JC; Vielh P; Besse B; Farace F
J Clin Oncol; 2013 Jun; 31(18):2273-81. PubMed ID: 23669222
[TBL] [Abstract][Full Text] [Related]
39. Diversity of genomic breakpoints in TFG-ALK translocations in anaplastic large cell lymphomas: identification of a new TFG-ALK(XL) chimeric gene with transforming activity.
Hernández L; Beà S; Bellosillo B; Pinyol M; Falini B; Carbone A; Ott G; Rosenwald A; Fernández A; Pulford K; Mason D; Morris SW; Santos E; Campo E
Am J Pathol; 2002 Apr; 160(4):1487-94. PubMed ID: 11943732
[TBL] [Abstract][Full Text] [Related]
40. Epithelioid inflammatory myofibroblastic sarcoma with VCL-ALK fusion of central nervous system: case report and brief review of the literature.
Chopra S; Maloney N; Wang WL
Brain Tumor Pathol; 2022 Jan; 39(1):35-42. PubMed ID: 34743247
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
